The next step in medical anti-corruption: strict investigation of phase IV clinical and unified prescription


Release time:

2014-12-28


Does the anti-unification software want to take off?
"Tongfang" is the hospital's statistics on the amount of medication used by doctors. In the current drug rebate, Tongfang can be said to be a key link. Determining the number of drugs prescribed is the basis for the final realization of the rebate.
Anti-unification software is not a new thing, but it has not been promoted on a large scale because it is contrary to the interests of hospitals and doctors. Now the administration is forcing hospitals to install anti-unification software, and there should be no problem in expanding the installation rate.
However, if the recent exposure of antibiotic contamination incidents, the installation of the software is only the first step, and it is the most important thing to really play a role. How to really make the hospital have the motivation to use this software, so that doctors do not rely on kickbacks, this is probably the policy should do the most. In the case of no real reform of the medical system, it is worth pondering how much effect the installation of anti-unification software can play.
The next step is to investigate the four clinical
Phase IV clinical is a clinical study of a new drug after it is marketed. Its purpose is to investigate the efficacy and adverse reactions of the drug under widely used conditions, to evaluate the relationship between benefits and risks in the general or special population, and to improve the dosage of the drug. Companies will generally pay doctors for this.
However, including foreign countries, this phase IV clinic has been deformed and has become a disguised way to encourage doctors to prescribe drugs. Last year, some media also exposed well-known foreign pharmaceutical companies abroad to pay bribes to doctors in disguised form in the name of phase IV clinic.
At that time, after the media questioned the publication, it caused widespread discussion in the industry. It has always been a vague area as to how to do the fourth phase of the clinic and what is the fourth phase. At the time, RDPAC argued that in Phase IV, doctors and nurses were involved in gathering information and were entitled to a return.
The above-mentioned industry insiders said that although phase IV clinical practice is an international practice, with the gradual advancement of medical anti-corruption, it is becoming the next target of strict investigation, which will focus on whether doctors' behavior in phase IV clinical practice is compliant.
Cyberlan believes that it is undeniable that there is the possibility of commercial bribery in some phase IV clinical studies. Previous academic conferences have also been severely cracked down. In the past, because of what kind of academic conferences are compliant, there was no unified official statement., So many companies are thinking about what academic conferences should do. Later, enterprises are also talking about groping the path. In addition to the strict investigation of phase IV clinical practice, I am afraid that the establishment of rules should also be the proper meaning.